Physiologic Effects of CPAP After Vascular Surgery (PhyCUS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03543930 |
|
Recruitment Status : Unknown
Verified June 2018 by Paolo Pelosi, University of Genova.
Recruitment status was: Recruiting
First Posted : June 1, 2018
Last Update Posted : July 3, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Postoperative Complications Respiratory Failure | Device: Postoperative preventive CPAP |
| Study Type : | Observational |
| Estimated Enrollment : | 18 participants |
| Observational Model: | Case-Crossover |
| Time Perspective: | Prospective |
| Official Title: | Physiologic Effects of CPAP After Vascular Surgery |
| Actual Study Start Date : | May 25, 2018 |
| Estimated Primary Completion Date : | May 25, 2019 |
| Estimated Study Completion Date : | July 1, 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Major open vascular surgery
Surgical procedures on the abdominal aorta requiring median abdominal incision
|
Device: Postoperative preventive CPAP
Administration of a course of 2 hours of CPAP with 7.5 cmH2O pressure and 0.30 FIO2 |
|
Endovascular aortic repair
Abdominal aortic repair with endovascular approach
|
Device: Postoperative preventive CPAP
Administration of a course of 2 hours of CPAP with 7.5 cmH2O pressure and 0.30 FIO2 |
- PaO2/FIO2 ratio [ Time Frame: Two hours after the administration of CPAP ]Increase of the PaO2/FIO2 ratio compared to the baseline value
- Esophageal pressure-time product (PTPes) [ Time Frame: Two hours after the administration of CPAP ]Increase of the PTPes compared to the baseline value
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Open or endovascular surgery on the abdominal aorta
- Surgical procedure requiring general anaesthesia and invasive intraoperative mechanical ventilation
- Intermediate-high risk of postoperative pulmonary complications (ARISCAT score ≥ 26)
Exclusion Criteria:
- Prolonged post-operative invasive ventilation
- Invasive or non-invasive ventilation or oxygen therapy in the last month
- ASA class IV or V
- Emergency procedures
- Pneumothorax or active pulmonary infection
- Any contraindication to CPAP
- Prolonged bed rest
- Patient refusal to participate or to receive preventive CPAP
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03543930
| Contact: Paolo Pelosi, Prof. | +39 335 5941740 | ppelosi@hotmail.com |
| Italy | |
| Policlinico San Martino | Recruiting |
| Genova, Italy, 16132 | |
| Contact: Paolo Pelosi, Professor +39 010 5554970 ppelosi@hotmail.com | |
| Principal Investigator: Paolo Pelosi, Chief of ICU | |
| Sub-Investigator: Lorenzo Ball, MD | |
| Principal Investigator: | Lorenzo Ball, MD | Università degli Studi di Genova |
| Responsible Party: | Paolo Pelosi, Prof., University of Genova |
| ClinicalTrials.gov Identifier: | NCT03543930 |
| Other Study ID Numbers: |
PhyCUS Study |
| First Posted: | June 1, 2018 Key Record Dates |
| Last Update Posted: | July 3, 2018 |
| Last Verified: | June 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Respiratory Insufficiency Postoperative Complications Respiration Disorders Respiratory Tract Diseases Pathologic Processes |

